GALWAY, Ireland, April 7, 2026 /PRNewswire/ — InVera Medical, a medical device company focused on advancing minimally-invasive technologies for Chronic Venous Disease, has received FDA 510(k) clearance for the InVera Infusion Device, a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, including varicose veins.

Chronic Venous Disease (CVD) affects one in four adults and can progress from visible varicose veins to painful leg ulcers, if left untreated. Despite affecting over 120 million people across the US and Europe, only 1% of those living with venous disease currently receive treatment each year, underlining a significant gap in care that InVera aims to address.